Figure 1. Cellular Iron Metabolism
A generic mammalian cell is depicted with an indication of iron import (top) as well as iron export (bottom) pathways. The transferrin receptor-1 (TfR1) is ubiquitously expressed, while transferrin receptor-2 (TfR-2) is restricted to hepatocytes, duodenal crypt cells, and erythroid cells. Polarized epithelial cells of the kidney utilize cubilin for transferrin-mediated iron uptake. DMT-1 is implicated in intestinal iron absorption after Fe 3ϩ from the diet is reduced to Fe 2ϩ by the cytochrome b-like ferrireductase (Dcytb). DMT-1 further functions in iron export from the endosome following uptake via the Tf cycle. The hemoglobin scavenger receptor (CD163) plays a role in haptoglobin-mediated hemoglobin uptake of monocytes and macrophages. The only putative iron exporter identified to date is ferroportin, which has been implicated in iron export from duodenal enterocytes, macrophages, hepatocytes, placenta syncytiotrophoblasts, and cells of the central nervous system (CNS). Ceruloplasmin, and its intestinal homolog hephaestin, oxidize Fe 2ϩ after cellular iron export for loading onto transferrin. Much intracellular iron traffic is directed toward mitochondria, where the iron-dependent step of heme synthesis and critical steps for Fe-S cluster biogenesis are localized. Regulation of Cellular Iron Homeostasis Proteins involved in iron uptake, storage, utilization, and held in storage, and the remainder is exported to reload circulating Tf. This is quantitatively important; only 1-2 export must be regulated in a coordinated fashion. The signals and regulatory mechanisms that orchestrate mg of iron enters the body through the intestine each day, yet 25 mg are needed for erythropoiesis and other their expression involve modulation of transcription, mRNA stability, translation, and posttranslational modiuses. Nearly all of the available iron pool is derived from macrophage recycling (Figure 3) .
fications. Posttranscriptional regulation is best characterized (Figure 2 ). Trans-acting iron regulatory proteins Cellular Iron Storage Once iron enters the cell, the portion that is not needed (IRPs) interact with iron-responsive elements (IREs), which are conserved hairpin structures found in untransfor immediate use is stored by ferritin, a ubiquitous and highly conserved multimeric protein (Figure 1) involves a soluble factor, the factor is short-lived, or the Recently, it was proposed that an Fe-S protein might signal results from a decrease, rather than increase, in act as a sensor of the mitochondrial iron status. If this its production. A possible caveat to this interpretation putative sensor lacks its Fe-S cluster, mitochondrial iron is the fact that Tf levels are unusually low. However, a would accumulate through increased mitochondrial iron similar predominance of the erythroid regulator is apparuptake and/or decreased iron release. Iron sequestraent in patients with thalassemia syndromes. They have tion would continue until requirements for Fe-S cluster increased erythropoietic drive due to destruction of imassembly were satisfied. Thereafter, the amount of iron mature erythroid cells in the bone marrow, leading to remaining in a postmitochondrial, cytoplasmic iron pool increased intestinal iron absorption even after other tiswould be sensed, in some fashion, to regulate cellular sues become iron overloaded. iron absorption (Pandolfo, 2002). However, mutations Cellular iron retention occurs rapidly in the settings in aminolevulinate synthase, the first enzyme in heme of infection and inflammation, presumably to withhold synthesis, also cause mitochondrial iron accumulation. a nutrient from invading pathogens. Iron accumulates This suggests a more complicated process for regulatin macrophages that recycle the metal from senescent ing mitochondrial iron influx. erythrocytes, and intestinal iron absorption is interrupted. This can be considered an "inflammatory regulator."
Systemic Iron Homeostasis
These different regulators (erythroid, stores, hypoxia, and Systemic Regulators inflammatory) need not be completely independent. Systemic iron homeostasis, the control of iron balance Rather, they might represent quantitative differences in throughout the body, requires mechanisms for regulatresponses mediated by the same molecule(s). ing iron entry into and mobilization from stores, for meetSerum plasma iron levels are determined both by ining erythropoietic needs, and for scavenging previously testinal absorption and macrophage recycling of iron used iron. There is no efficient pathway for iron excrefrom hemoglobin (Figure 3) . Regulatory effectors that tion; hence, intestinal absorption must be modulated to modulate intestinal iron absorption probably also moduprovide enough (but not too much) iron to keep stores late release of iron from tissue macrophages and hepareplete and erythroid demands met. There must be eftocytes. The search for these molecules has focused fective communication between cells that consume iron on plasma proteins that might act at multiple sites. Some (primarily erythroid precursors) and cells that acquire plausible candidates, e.g., erythropoietin, have likely and store iron (duodenal enterocytes, hepatocytes, tisbeen ruled out (Raja et al., 1986 ). sue macrophages). Transfer between tissues must be Hepcidin (HAMP, LEAP) appears to be such a regulaorchestrated to maintain homeostasis (Figure 3) . suggested that hepcidin predominantly acted to dimincultured hepatic cells; in fact, ferric iron treatment led ish iron transport across the apical membrane, with little to decreased hepcidin production. No molecular link or no effect on basolateral iron transfer. However, the has yet been found between hepcidin expression and effects were small, and a time lag between hepcidin the erythroid and hypoxia regulators. injection and effect on absorption makes the experiIs hepcidin the sole downstream effector for all four ments difficult to interpret. It will be important to resolve regulators described above? Although hepcidin producthis issue in future studies. tion is attenuated when erythropoiesis is iron restricted, No hepcidin receptor has been identified to date, but activation of the erythroid regulator in Trf hpx mice also it is assumed that hepcidin interacts with a cell surface leads to markedly increased expression of Dmt1, ferro- Hepcidin is an antimicrobial, ␤ defensin-like peptide secreted by the liver. It diminishes iron release from reticuloendothelial macrophages and duodenal enterocytes. As a consequence, serum iron levels decrease. Hepcidin expression is regulated by iron levels, inflammatory stimuli, the erythroid iron demand, and hypoxia. Recent data indicate that the former two responses require HFE function. The prototype, HLA-linked hemochromatosis, is characterized by iron accumulation in the liver, heart, and elevated serum ferritin and increased liver iron. As discussed later, they develop a neurodegenerative phenopancreas, with relative sparing of macrophages. Complications, resulting from destructive changes, include type. Tissue-specific ablation of IRP2 will be necessary to elucidate how loss of this protein leads to these proliver cirrhosis, heart failure, and diabetes. When identified before severe damage ensues, hemochromatosis tean manifestations.
IRE/IRP in Systemic Iron Homeostasis Autosomal dominant hyperferritinemia-cataract syndrome is caused by loss-of-function mutations in the
Interestingly, a single point mutation in the IRE of can be treated by phlebotomy (blood-letting) to remove iron-rich red blood cells. Although now deleterious, the ferritin H chain mRNA (A49U) is associated with autosomal dominant iron overload affecting three members of hemochromatosis mutation may have been subject to positive selection at times when the diet provided little a Japanese family (Kato et al., 2001) to the idea of an HFE/hepcidin axis. The normal function of HFE is unknown. Importantly, Some non-HFE hemochromatosis patients carry nonit forms a high-affinity complex with TfR1 ( sis has generated new classes of mutant mice (Table Together, these observations suggest that (1) HFE and 1), which serve three general purposes: development of hepcidin are parts of the same regulatory axis and (2) mouse models of human diseases (e.g., hemochro-HFE might function "upstream" of hepcidin expression matosis, aceruloplasminemia, Friedreich's ataxia), inter- (Figure 4 ). New models for HFE function must take these rogation of the roles of iron-related proteins in vivo (e.g., TfR1, H-ferritin, IRPs), and discovery of previously unfacts into account. In spite of these multiple links between iron metabophysiological function of hepcidin as an antimicrobial lism, neuronal function, and neurodegeneration, we are effector of the innate immune response warrants further still far from understanding many basic aspects of iron investigation, the structural similarities between hepmetabolism in the brain. Further convergence between cidin and the ␤-defensins suggests another intriguing neurobiology and the study of iron metabolism will conevolutionary link. These connections and parallels can tribute critical insights into normal brain function and be rationalized to some extent by considering that iron common neuropathologies. is an essential nutrient for invading microbes, and sequestration of iron is an effective measure against them.
The Challenges Ahead Undoubtedly, however, there are other important links Although proteins required for heme biosynthesis and that are yet to be discovered and understood. H-ferritin allele leads to increases in brain markers of
